Please assess the completion status of the following clinical trial:

Trial Title: A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be scheduled to have 2 or more third molars removed, at least 1 of which is partially embedded in bone and is impacted in the lower jaw~* Patients must be experiencing moderate to severe pain following the dental procedure~Exclusion Criteria:~* Previous molar extraction within the past 45 days~* Personal or family history of an inherited bleeding disorder~* Uncontrolled high blood pressure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): etoricoxib 90 mg
- 2 (Type: EXPERIMENTAL): etoricoxib 120 mg
- 3 (Type: ACTIVE_COMPARATOR): ibuprofen 2400 mg
- 4 (Type: ACTIVE_COMPARATOR): acetaminophen 2400 mg/codeine 240 mg
- 5 (Type: PLACEBO_COMPARATOR): Matching Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).